(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 3.83% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Revvity's revenue in 2026 is $2,911,811,000.On average, 23 Wall Street analysts forecast RVTY's revenue for 2026 to be $325,943,877,321, with the lowest RVTY revenue forecast at $311,102,885,988, and the highest RVTY revenue forecast at $349,042,262,328. On average, 23 Wall Street analysts forecast RVTY's revenue for 2027 to be $343,016,596,674, with the lowest RVTY revenue forecast at $325,274,358,915, and the highest RVTY revenue forecast at $364,775,944,869.
In 2028, RVTY is forecast to generate $364,664,358,468 in revenue, with the lowest revenue forecast at $340,673,282,253 and the highest revenue forecast at $386,423,706,663.